| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.82▼ | 3.85▼ | 3.85▼ | 3.93▼ | 3.87▼ |
| MA10 | 3.82▼ | 3.84▼ | 3.83▼ | 3.85▲ | 4.13▼ |
| MA20 | 3.80▼ | 3.83▼ | 3.81▼ | 3.77▲ | 4.77▼ |
| MA50 | 3.92▼ | 3.76▼ | 3.75▼ | 4.27▼ | 4.65▼ |
| MA100 | 3.85▼ | 4.05▼ | 4.12▼ | 5.04▼ | 61.82▼ |
| MA200 | 4.15▼ | 4.68▼ | 4.85▼ | 4.86▼ | 2,596.66▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | -0.011▼ | -0.004▼ | 0.069▲ | 0.461▲ |
| RSI | 43.130▼ | 46.996▼ | 46.279▼ | 46.910▼ | 37.715▼ |
| STOCH | 42.063 | 56.300 | 55.198 | 33.647 | 20.836 |
| WILL %R | -100.000▼ | -75.758▼ | -83.158▼ | -80.711▼ | -79.902▼ |
| CCI | -114.874▼ | -104.624▼ | -121.527▼ | -2.244 | -94.242 |
|
Thursday, February 26, 2026 05:36 AM
ENDRA Life Sciences Inc. (NASDAQ: NDRA) ("ENDRA" or the "Company"), a pioneer in thermoacoustic biomarker imaging for the early detection and monitoring of steatotic liver disease (SLD), today ...
|
|
Friday, December 05, 2025 04:00 PM
Fintel reports that on December 8, 2025, Ascendiant Capital maintained coverage of ENDRA Life Sciences (NasdaqCM:NDRA) with a Buy recommendation. As of December 6, 2025, the average one-year price ...
|
|
Wednesday, December 03, 2025 09:01 PM
Feasibility study data at 12-22% liver fat cutoffs validate TAEUS as a potential low-cost, point-of-care alternative to MRI-PDFF for patient stratification and trial monitoring ENDRA Life Sciences Inc ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 03/03/26 | 3.84 | 3.85 | 3.6401 | 3.85 | 16,912 |
| 02/03/26 | 3.75 | 3.94 | 3.60 | 3.92 | 43,470 |
| 27/02/26 | 3.80 | 4.23 | 3.72 | 4.15 | 88,992 |
| 26/02/26 | 4.24 | 5.94 | 3.51 | 3.92 | 4,454,364 |
| 25/02/26 | 3.78 | 3.89 | 3.5001 | 3.81 | 5,976 |
| 24/02/26 | 3.75 | 3.9391 | 3.75 | 3.86 | 5,352 |
| 23/02/26 | 3.82 | 3.938 | 3.70 | 3.75 | 11,500 |
| 20/02/26 | 3.82 | 4.24 | 3.75 | 3.95 | 18,390 |
| 19/02/26 | 3.37 | 3.96 | 3.37 | 3.825 | 16,371 |
| 18/02/26 | 3.63 | 3.70 | 3.37 | 3.45 | 16,496 |
|
|
||||
|
|
||||
|
|